Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological Responsiveness
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
- Status
- RECRUITING
- Phase
- N/A
A Study of Samuraciclib and Elacestrant in Participants With Metastatic or Locally Advanced HR+/HER2-negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants
- Status
- COMPLETED
- Phase
- PHASE2
89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
- Status
- UNKNOWN
- Phase
- PHASE1
Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) Subtype
- Status
- RECRUITING
- Phase
- PHASE3
Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
DESTINY Breast Respond HER2-low Europe
- Status
- RECRUITING
- Phase
- N/A
Study of OB-002 in Patients With Refractory Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
The Impact of Radiotherapy on Oligometastatic Cancer
- Status
- RECRUITING
- Phase
- N/A
Study of TFX06 in Women With Advanced Breast Cancer.
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Trastuzumab Deruxtecan (T-DXd): Tailoring Treatment and Companion Diagnostics (CDx) by Liquid Biopsy
- Status
- RECRUITING
- Phase
- NA
Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
- Status
- RECRUITING
- Phase
- N/A
Estradiol Plus Olaparib for Breast Cancer (PHOEBE)
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Tucatinib Given Before Surgery to People With HER2+ Cancers That Have Spread to the Brain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PRE-I-SPY Phase I/Ib Oncology Platform Program
- Status
- RECRUITING
- Phase
- PHASE1
HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease
- Status
- COMPLETED
- Phase
- PHASE2
SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers
- Status
- RECRUITING
- Phase
- PHASE2
Second Line ERIbulin Followed by CApecitabine or the Reverse Sequence in HER2-negative Metastatic Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2